Boon Cher Goh

10PUBLICATIONS
63CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 17, 2026
A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas.

|Apr 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Bhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao

|Jun 26, 2025
Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non-Small Cell Lung Cancer (LIQUIK).

Jens Samol, David Ng, Jonathan Poh

|Jan 13, 2023
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.

Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun

|Sep 28, 2021
Epigenetic derepression converts PPARĪ³ into a druggable target in triple-negative and endocrine-resistant breast cancers.

Ser Yue Loo, Nicholas L Syn, Angele Pei-Fern Koh

|Apr 17, 2021
DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death.

Heng Boon Low, Zhen Lim Wong, Bangyuan Wu

Pageof 2

Frequent Collaborators

4 joint publications

Li Ren Kong

4 joint publications

Tuan Zea Tan

4 joint publications

Brigette Ma

2 joint publications

Nicholas L Syn